Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Ocular Therapeutix Inc. buy Bank of America Co.

Ocular Therapeutix Inc.
Start price
€5.02
09.02.24 / 50%
Target price
€13.91
09.02.25
Performance (%)
45.42%
End price
€7.30
10.02.25
Summary
This prediction ended on 10.02.25 with a price of €7.30. With a performance of 45.42% the BUY prediction by Bank_of_America_Co_ was a big success. Bank_of_America_Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Ocular Therapeutix Inc. 9.434% 9.434% -19.816%
iShares Core DAX® 0.437% 5.640% 7.806%
iShares Nasdaq 100 1.057% 0.282% 27.239%
iShares Nikkei 225® 1.769% 0.406% 49.266%
iShares S&P 500 0.368% 1.920% 22.336%

Comments by Bank_of_America_Co_ for this prediction

In the thread Ocular Therapeutix Inc. diskutieren
Prediction Buy
Perf. (%) 45.42%
Target price 13.907
Change
Ends at 09.02.25

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $15.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat

Bank of America Co. 
0
Report Share
09.02.24
In the thread Trading Ocular Therapeutix Inc.
Prediction Buy
Perf. (%) 45.42%
Target price 13.907
Change
Ends at 09.02.25

Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten

Bank of America Co. 
0
Report Share
10.02.25